GlassScriptPhysician profile
James K Duncan
NPI 1861485864
$1,767.91
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $43.75 · 2021: $286 · 2022: $229 · 2023: $154 · 2024: $55.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $511.00 | 2019 | |
| Arthrex, INC. | $442.00 | 2019 | |
| Osteomed LLC | $281.89 | 2021-2022 | |
| Stryker Corporation | $244.37 | 2020-2023 | Actishield |
| Paragon 28, INC. | $75.69 | 2023 | Apex 3d |
| Organogenesis INC. | $72.58 | 2022 | |
| Treace Medical Concepts, INC. | $29.65 | 2024 | |
| Ets Wound Care LLC | $25.43 | 2024 | Mirragen Advanced Wound Matrix |
| Aroa Biosurgery Incorporated | $22.78 | 2019 | |
| Heron Therapeutics, INC. | $22.34 | 2023 | Zynrelef |
| Kci USA, INC. | $15.43 | 2020 | |
| Convatec INC. | $12.99 | 2019 | |
| Biocomposites INC | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.